Cite
Anti-MDA5 Antibody-positive Dermatomyositis with Rapidly Progressive Interstitial Pneumonia Presenting with Nephrotic Syndrome during Treatment with Corticosteroids and Cyclosporine.
MLA
Shinya Kawamoto, et al. “Anti-MDA5 Antibody-Positive Dermatomyositis with Rapidly Progressive Interstitial Pneumonia Presenting with Nephrotic Syndrome during Treatment with Corticosteroids and Cyclosporine.” Internal Medicine, vol. 61, no. 13, July 2022, pp. 2007–12. EBSCOhost, https://doi.org/10.2169/internalmedicine.8311-21.
APA
Shinya Kawamoto, Toshihiro Abe, Katsuhiro Nagahori, Atsunori Yoshino, Akiko Fujii, Yuko Ono, Yoshihiko Ueda, & Tetsuro Takeda. (2022). Anti-MDA5 Antibody-positive Dermatomyositis with Rapidly Progressive Interstitial Pneumonia Presenting with Nephrotic Syndrome during Treatment with Corticosteroids and Cyclosporine. Internal Medicine, 61(13), 2007–2012. https://doi.org/10.2169/internalmedicine.8311-21
Chicago
Shinya Kawamoto, Toshihiro Abe, Katsuhiro Nagahori, Atsunori Yoshino, Akiko Fujii, Yuko Ono, Yoshihiko Ueda, and Tetsuro Takeda. 2022. “Anti-MDA5 Antibody-Positive Dermatomyositis with Rapidly Progressive Interstitial Pneumonia Presenting with Nephrotic Syndrome during Treatment with Corticosteroids and Cyclosporine.” Internal Medicine 61 (13): 2007–12. doi:10.2169/internalmedicine.8311-21.